Literature DB >> 35673475

Genetic variants of ALR (-106C → T /-12C → G) and serum PKC-δ are associated with peripheral neuropathy in Egyptian diabetic patients with impaired handwriting.

Shaimaa A Fattah1, Moshira Elmadani2, Dina M Abo-Elmatty1, Mohamed Awadallah2, Eman T Mehanna1.   

Abstract

Purpose: Diabetic peripheral neuropathy can injure the hand median nerve and cause extensive nerve damage. PKC and ALR are associated with progression of diabetic complications. We hypothesized a genetic association between the ALR polymorphisms (-106C → T/-12C → G) and elevated serum PKC-δ levels in diabetic neuropathy and its adverse effects on handwriting in Egyptian population.
Methods: One hundred DPN were compared with 100 DP and 100 healthy volunteers. ALR -106C → T/-12C → G variants were studied using the PCR-RFLP method. A routine set of standard laboratory markers was determined. Serum PKC-δ concentration was determined by ELISA. Logistic regression analysis and areas under the receiver characteristic curves (AUCs) were evaluated to investigate the predictors of diabetic neuropathy. Arabic handwriting was analyzed based on the recognition of functional features, word shape, and ascending/descending parts of letters.
Results: Individuals carrying ALR-106C → C and -12G → G had a significantly higher risk of developing diabetic neuropathy than individuals with -106C → T and -12C → G genotypes (P = 0.01, P = 0.02). Carriers of the (-106C → T) CC and (-12C → G) GG genotypes had significantly increased serum levels of PKC-δ, FBG, TC, and LDL-c. PKC- δ serum levels were significantly correlated with glycemic and lipid indicators (P < 0.001). PKC-δ is a significant predictor of diabetes with or without neuropathy at a cutoff value of 16.6, sensitivity was 89%, and specificity 100%. All DPN showed complete deterioration of handwriting after the onset of diabetic neuropathy.
Conclusion: The genetic variants ALR-106C → C / -12G → G and PKC-δ in serum may help in the detection and treatment of diabetic neuropathy in Egyptian population before writing performance is affected. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  ALR − 106C → T and − 12C → G polymorphisms; Diabetic neuropathy; Handwriting performance; PCR–RFLP; PKC-δ

Year:  2022        PMID: 35673475      PMCID: PMC9167348          DOI: 10.1007/s40200-022-01008-0

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  29 in total

1.  Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats.

Authors:  R E Roberts; W G McLean
Journal:  Brain Res       Date:  1997-04-18       Impact factor: 3.252

Review 2.  Diabetic retinopathy.

Authors:  Robert N Frank
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

3.  Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells.

Authors:  Kota V Ramana; Brian Friedrich; Ravinder Tammali; Matthew B West; Aruni Bhatnagar; Satish K Srivastava
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

4.  Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese Type 2 diabetic (T2DM) patients.

Authors:  H Shimizu; K I Ohtani; T Tsuchiya; N Sato; Y Tanaka; H Takahashi; Y Uehara; T Inukai; M Mori
Journal:  Diabetes Nutr Metab       Date:  2000-04

5.  Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest.

Authors:  Ademi E Santiago-Walker; Aphrothiti J Fikaris; Gary D Kao; Eric J Brown; Marcelo G Kazanietz; Judy L Meinkoth
Journal:  J Biol Chem       Date:  2005-07-28       Impact factor: 5.157

6.  Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes.

Authors:  K Sivenius; L Niskanen; R Voutilainen-Kaunisto; M Laakso; M Uusitupa
Journal:  Diabet Med       Date:  2004-12       Impact factor: 4.359

7.  Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.

Authors:  Irina G Obrosova; Alexander G Minchenko; Rukmini Vasupuram; Lauren White; Omorodola I Abatan; Arno K Kumagai; Robert N Frank; Martin J Stevens
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

8.  Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats.

Authors:  E J Lehning; R M LoPachin; J Mathew; J Eichberg
Journal:  J Toxicol Environ Health       Date:  1994-07

9.  Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation.

Authors:  Richard Gordon; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  J Neuroinflammation       Date:  2012-04-27       Impact factor: 8.322

10.  PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway.

Authors:  Manikandan Samidurai; Bharathi N Palanisamy; Alejandra Bargues-Carot; Monica Hepker; Naveen Kondru; Sireesha Manne; Gary Zenitsky; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Front Aging Neurosci       Date:  2021-07-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.